Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTIBODY SPECIFICALLY BINDING TO V5 EXON OF CD44, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/093147
Kind Code:
A1
Abstract:
The present invention relates to an antibody specifically binding to the v5 exon of human CD44 or a fragment thereof. The present invention also relates to a chimeric antigen receptor molecule comprising the antibody or the fragment thereof, a nucleic acid molecule, a recombinant vector and a cell for encoding the antibody or the fragment thereof and the chimeric antigen receptor molecule, or an antibody-drug conjugate containing the antibody. The present invention further relates to the use of the antibody, the chimeric antigen receptor molecule or the antibody-drug conjugate.

Inventors:
SHEN PINGPING (CN)
BEI YUNCHENG (CN)
Application Number:
PCT/CN2023/087794
Publication Date:
May 10, 2024
Filing Date:
April 12, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MACERA THERAPEUTICS (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C07K19/00; C12N5/10; C12N15/09; C12N15/13
Domestic Patent References:
WO2005007700A12005-01-27
WO1995004547A11995-02-16
Foreign References:
CN106061496A2016-10-26
US20030108984A12003-06-12
KR20150142306A2015-12-22
CN101605812A2009-12-16
CN110776559A2020-02-11
US20030190319A12003-10-09
Attorney, Agent or Firm:
IPSUNNY (CN)
Download PDF: